Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and Staging are the critical first steps in managing stomach cancer, determining the disease’s extent and informing the most effective treatment plan. At Liv Hospital, an internationally accredited center, our multidisciplinary team combines state‑of‑the‑art technology with expert clinical judgment to provide precise, patient‑centered care. Each year, stomach cancer accounts for over 1 million new cases worldwide, and early, accurate assessment dramatically improves survival odds. This page guides patients and caregivers through the comprehensive pathway—from initial clinical evaluation to the final staging report—ensuring transparency and confidence in every decision.
International patients choosing Liv Hospital benefit from coordinated services that include medical translation, travel logistics, and comfortable accommodation, allowing them to focus solely on health outcomes. Below, we detail each component of the diagnostic and staging process, highlighting the tools, procedures, and collaborative steps that define our approach.
The journey begins with a thorough clinical interview and physical examination. Our gastroenterology specialists collect detailed medical histories, focusing on symptoms such as persistent indigestion, unexplained weight loss, or gastrointestinal bleeding. A risk‑assessment questionnaire also captures lifestyle factors, family history of malignancy, and prior Helicobacter pylori infection, which is a known contributor to gastric neoplasia.
Key elements of the initial evaluation include:
Based on these findings, patients are stratified into low, intermediate, or high suspicion categories, which dictate the urgency and type of subsequent investigations. This systematic approach minimizes unnecessary procedures while ensuring high‑risk individuals receive prompt, targeted diagnostics.
Modern imaging is indispensable for visualizing the stomach’s anatomy and detecting metastatic spread. Liv Hospital employs a tiered imaging protocol, beginning with non‑invasive studies and escalating to high‑resolution modalities when indicated.
Common imaging modalities include:
Each imaging study contributes specific data that feed into the overall diagnosis and staging algorithm, allowing our oncologists to map the tumor’s size, location, and spread with confidence.
Endoscopy remains the gold standard for direct visualization and tissue acquisition. During an upper endoscopy (esophagogastroduodenoscopy, EGD), a high‑definition camera inspects the gastric mucosa, identifies suspicious lesions, and obtains targeted biopsies.
Key steps in the endoscopic workflow:
Biopsy specimens are promptly sent to our pathology laboratory, where they undergo histopathological grading (well‑, moderately, or poorly differentiated) and immunohistochemical staining for HER2, PD‑L1, and microsatellite instability (MSI). These molecular insights are integral to personalized therapy decisions, especially when targeted agents or immunotherapy are considered.
Accurate pathology is the cornerstone of reliable staging. After fixation, tissue sections are examined under a microscope to confirm adenocarcinoma and determine the grade. Concurrently, molecular profiling provides actionable data:
The integration of histology with molecular markers refines the stage grouping and influences both curative and palliative treatment pathways. Our multidisciplinary tumor board reviews each case, ensuring that the final report aligns with international guidelines such as the AJCC 8th edition.
The Tumor‑Node‑Metastasis (TNM) system remains the universal language for cancer staging. For stomach cancer, the classification captures tumor depth (T), regional lymph‑node involvement (N), and distant metastasis (M). Below is a concise overview used at Liv Hospital:
Accurate assignment of each component relies on the combined data from imaging, endoscopy, and pathology. The final stage not only predicts prognosis but also dictates whether curative surgery, neoadjuvant therapy, or palliative care is appropriate.
Once diagnosis and staging are complete, a personalized treatment plan is crafted by a tumor board comprising surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, radiologists, and supportive‑care specialists. The board evaluates:
Typical pathways include:
Liv Hospital’s integrated care model ensures seamless transitions between diagnostic phases and therapeutic interventions, minimizing delays and optimizing outcomes for international patients.
Liv Hospital combines JCI accreditation, cutting‑edge technology, and a dedicated international patient team to deliver world‑class cancer care. Our experts have extensive experience in gastric oncology, and we provide comprehensive support—from visa assistance to multilingual interpreters—so patients can focus solely on recovery. Choosing Liv Hospital means accessing personalized, evidence‑based treatment within a compassionate, culturally sensitive environment.
Ready to start your journey toward accurate diagnosis and tailored treatment? Contact Liv Hospital today to schedule a virtual consultation with our gastric cancer specialists. Let us handle the logistics while you prioritize your health.
Send us all your questions or requests, and our expert team will assist you.
During the initial clinical evaluation, gastroenterology specialists collect a comprehensive medical history focusing on persistent indigestion, weight loss, and gastrointestinal bleeding. A physical examination looks for abdominal tenderness or palpable masses. Laboratory tests such as CBC, liver function, and tumor markers (CEA, CA 19‑9) are ordered, and nutritional status is assessed using scales like ECOG. Based on these findings, patients are stratified into low, intermediate, or high suspicion categories, which determines the urgency of further imaging or endoscopic investigations. This systematic approach minimizes unnecessary procedures while ensuring high‑risk patients receive prompt, targeted diagnostics.
The imaging protocol starts with a non‑invasive Upper Gastrointestinal (UGI) barium study to identify structural abnormalities. If further detail is needed, a contrast‑enhanced CT scan provides rapid 3‑D visualization of local tumor depth and distant spread. MRI offers superior soft‑tissue contrast, especially for liver lesions, without ionizing radiation. PET‑CT adds metabolic information, detecting occult metastases with high sensitivity. Endoscopic ultrasound (EUS) delivers layer‑by‑layer assessment of tumor depth and guides fine‑needle aspiration of suspicious lymph nodes. Each modality contributes specific data that feed into the overall staging algorithm.
During an upper endoscopy, a high‑definition camera inspects the gastric mucosa, and if a lesion is found, an endoscopic ultrasound probe is introduced. EUS provides real‑time, high‑resolution images of the gastric wall layers, enabling clinicians to determine whether the tumor is confined to the mucosa, submucosa, muscularis, or has penetrated the serosa. Additionally, EUS can target regional lymph nodes for fine‑needle aspiration, yielding cytology that confirms nodal involvement. This information refines the N component of the TNM classification, influencing decisions about neoadjuvant therapy versus upfront surgery.
For stage IA‑IB tumors, curative gastrectomy with adequate lymph‑node dissection is standard. Stages II‑III typically receive peri‑operative chemotherapy or chemoradiotherapy to shrink the tumor before resection, improving resectability and survival. If HER2 is overexpressed, trastuzumab is incorporated into the regimen. MSI‑high or PD‑L1‑positive tumors may be treated with checkpoint inhibitors, either alone or in combination with chemotherapy. Stage IV disease, characterized by distant metastasis (M1), is managed with systemic chemotherapy, targeted agents, or immunotherapy to control disease and alleviate symptoms. Palliative radiotherapy and supportive care are added as needed.
International patients benefit from a coordinated service that includes multilingual interpreters, assistance with visa applications, and organized travel arrangements. The hospital offers comfortable lodging close to the treatment center, reducing the stress of navigating an unfamiliar environment. A dedicated international patient coordinator ensures that all appointments—clinical evaluation, imaging, endoscopy, and pathology—are scheduled efficiently, minimizing wait times. This comprehensive support allows patients to focus on their health while the hospital handles logistical and administrative details.
BlogCancerFeb 18, 2026Medical imaging tests, like CT scans, use contrast agents to make internal structures clearer. These substa...
BlogCancerNov 03, 2025Bloated stomach is a common symptom of stomach cancer, often indicating progression or metastasis. Our expe...
BlogCancerNov 03, 2025Stomach cancer is one of the deadliest forms of cancer, with only 7% of those with metastatic disease survi...
BlogCancerSep 30, 2025Can stomach cancer cause itchy skin? Many people are unaware that stomach cancer can present in unusual way...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 26 75
